Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

BIOMARIN PHARMACEUTICAL INC.

(924801)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über BIOMARIN PHARMACEUTICAL INC.
30.11.BIOMARIN TO HOLD VIRTUAL R&D DAY AT : 00am ET Today
29.11.BioMarin to Participate in Two Upcoming Virtual Investor Conferences
23.11.INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claims Against ..
23.11.INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Bio..
19.11.BioMarin Gets FDA Approval for Voxzogo in Pediatric Patients With Bone Growth Disorder;..
19.11.FDA OKs BioMarin's Voxzogo for Children With Most Common Form of Dwarfism
19.11.BioMarin Receives FDA Approval for VOXZOGO™ (vosoritide) for Injection, Indicated..
19.11.Biomarin Pharmaceutical Inc. Receives FDA Approval for Voxzogo? for Injection
18.11.Novartis Said Considering Takeover in Biotech Sector
15.11.Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos' Fus..
03.11.BIOMARIN PHARMACEUTICAL INC : Change in Directors or Principal Officers (form 8-K)
03.11.BioMarin Pharmaceutical Inc. Announces Management Changes, Effective January 28, 2022
01.11.SHAREHOLDER ALERT : Robbins LLP Announces that BioMarin Pharmaceutical Inc. (BMRN) is Bein..
29.10.BIOMARIN PHARMACEUTICAL INC Management's Discussion and Analysis of Financial Conditio..
27.10.BioMarin Pharmaceutical Posts Q3 Net Loss, Reversing Year-Ago Profit
27.10.BIOMARIN : Q3 Earnings Snapshot
27.10.BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates - Form 8-..
27.10.Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Reports Q3 Revenue $408.7M
27.10.BioMarin Pharmaceutical Inc. Revises Earnings Guidance for the Full Year 2021
27.10.BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates
27.10.BioMarin Pharmaceutical Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
25.10.BIOMARIN PHARMACEUTICAL : to Participate in Four Upcoming Virtual Investor Conferences
12.10.BIOMARIN TO HOST THIRD QUARTER 2021 : 30pm ET
04.10.BIOMARIN PHARMACEUTICAL : Hires Industry Veterans to Fill Key Roles in R&D and Technical O..
04.10.BioMarin Pharmaceutical Inc. Hires Harold S. Bernstein as Chief Medical Officer and Hea..
20.09.SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioMa..
10.09.SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioMa..
09.09.A step closer to tapering
09.09.ANALYST RECOMMENDATIONS : Boohoo, Boston Beer, Cisco Systems, Eversource, Frontline...
07.09.Health Care Down As Rally In Sector Pauses -- Health Care Roundup
07.09.PPG Industries, BioMarin fall; AMC, Callaway Golf rise
07.09.Wall Street sluit overwegend lager
07.09.Health Care Stocks Falling This Afternoon
07.09.Health Care Stocks Flat To Lower Pre-Bell Tuesday
07.09.BIOMARIN PHARMACEUTICAL : Health Care
07.09.BIOMARIN PHARMACEUTICAL : Says FDA Orders Clinical Hold on Phase 1/2 Gene Therapy Trial in..
06.09.BIOMARIN PHARMACEUTICAL : U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 G..
06.09.Biomarin Pharmaceutical Inc. Announces U.S. FDA Placed Clinical Hold on BMN 307 Phearle..
30.08.BIOMARIN PHARMACEUTICAL : European Commission Approves BioMarin's VOXZOGO (vosoritide) for..
27.08.BIOMARIN PHARMACEUTICAL : European Commission Approves BioMarin's VOXZOGO® (vosoritide) fo..
27.08.European Commission Approves BioMarin’s VOXZOGO for the Treatment of Children with Acho..
27.08.BIOMARIN PHARMACEUTICAL : Receives European Commission Marketing Authorization for Voxzogo
27.08.BIOMARIN PHARMACEUTICAL : drug wins Europe's first approval for type of dwarfism
27.08.BIOMARIN PHARMACEUTICAL : Europe clears Biomarin drug for type of dwarfism in region's fir..
27.08.BIOMARIN PHARMACEUTICAL : European Commission Approves BioMarin's VOXZOGO® (vosoritide) fo..
27.08.BioMarin Gets European Commission Approval for Voxzogo
25.08.BIOMARIN PHARMACEUTICAL : to Participate in Three Upcoming Virtual Investor Conferences
04.08.INSIDER TRENDS : 90-Days of Insider Buying at BioMarin Pharmaceuticals Eased Back with Sha..
30.07.BIOMARIN PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and ..
28.07.BIOMARIN : Q2 Earnings Snapshot
28.07.BIOMARIN PHARMACEUTICAL : Debra Charlesworth (Form 8-K)
28.07.BIOMARIN PHARMACEUTICAL : Pharma Swings to Q2 Profit on Rising Revenue, Raises Full-Year G..
28.07.Biomarin Pharmaceutical Inc. Raises Earnings Guidance for the Full Year of 2021
28.07.BIOMARIN PHARMACEUTICAL : Announces Second Quarter 2021 Financial Results and Corporate Up..
28.07.BIOMARIN PHARMACEUTICAL : Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Reports Q2 Revenue..
28.07.EARNINGS REACTION HISTORY : Biomarin Pharmaceutical, 33.3% Follow-Through Indicator, 2.2% ..
22.07.BIOMARIN PHARMACEUTICAL : Announces Oral Presentation at International Society
21.07.BIOMARIN PHARMACEUTICAL : Pharma's Gene Therapy Candidate Shows Bleed Control Over Five Ye..
21.07.BIOMARIN PHARMACEUTICAL : Announces Oral Presentation at International Society on Thrombos..
21.07.BioMarin Pharmaceutical Inc. Announces Unaudited Consolidated Earnings Results for the ..
20.07.BIOMARIN PHARMACEUTICAL : Announces Oral Presentation of Positive One-Year Results from Ph..
19.07.BIOMARIN PHARMACEUTICAL : Announces Oral Presentation of Positive One-Year Results from Ph..
19.07.BioMarin Announces Oral Presentation of Positive One-Year Results from Phase 3 Pivotal ..
15.07.BIOMARIN PHARMACEUTICAL : European Regulator Accepts BioMarin's Marketing Application for ..
15.07.BIOMARIN PHARMACEUTICAL : European Medicines Agency Validates BioMarin's Marketing Authori..
15.07.European Medicines Agency Validates Biomarin's Marketing Authorization Application for ..
14.07.BIOMARIN TO HOST SECOND QUARTER 2021 : 30pm ET
05.07.BIOMARIN PHARMACEUTICAL : Findings to be Presented from Ongoing Studies of Valoctocogene R..
02.07.BIOMARIN PHARMACEUTICAL : Announces 12 Presentations at the International Society on Throm..
02.07.BIOMARIN PHARMACEUTICAL : Plaintiff Cannot Amend Statement Of Claim More Than 45 Days Afte..
29.06.BIOMARIN PHARMACEUTICAL : - Valoctocogene Roxaparvovec MAA Granted Request for Accelerated..
28.06.BIOMARIN PHARMACEUTICAL : Resubmits European Marketing Authorization Application for Gene ..
28.06.BIOMARIN PHARMACEUTICAL : Resubmits Marketing Authorization Application (MAA) to European ..
28.06.Biomarin Pharmaceutical Inc. Resubmits Marketing Authorization Application to European ..
25.06.BIOMARIN PHARMACEUTICAL : Says EMA Panel Supports Approval of Vosoritide to Treat Dwarfism..
1  2  3  4  5  6  7  8  9  10Weiter
Anstehende Termine für BIOMARIN PHARMACEUTICAL INC.